tiprankstipranks
Trending News
More News >
Bioventus, Inc. (BVS)
:BVS
US Market

Bioventus (BVS) Income Statement

Compare
186 Followers

Bioventus Income Statement

Last quarter (Q3 2025), Bioventus's total revenue was $138.65M, a decrease of -0.23% from the same quarter last year. In Q3, Bioventus's net income was $3.15M. See Bioventus’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 573.28M$ 512.35M$ 512.12M$ 430.90M$ 321.16M
Gross Profit
$ 388.23M$ 328.19M$ 331.08M$ 302.71M$ 233.52M
Operating Expenses
$ 400.20M$ 409.92M$ 498.31M$ 290.64M$ 212.28M
Depreciation and Amortization
$ 49.55M$ 57.37M$ 55.40M$ 34.88M$ 28.64M
EBITDA
$ 39.22M$ -23.07M$ -121.61M$ 45.48M$ 54.31M
Operating Income
$ -11.98M$ -81.72M$ -167.23M$ 12.06M$ 21.24M
Other Income/Expenses
$ -37.15M$ -39.39M$ -21.79M$ -2.57M$ -5.32M
Pretax Income
$ -49.13M$ -121.11M$ -189.03M$ 9.49M$ 15.91M
Net Income
$ -33.54M$ -156.23M$ -158.70M$ 19.38M$ 16.41M
Per Share Metrics
Basic EPS
$ -0.52$ -2.49$ -2.59$ -0.15$ 0.44
Diluted EPS
$ -0.52$ -2.49$ -2.59$ -0.15$ 0.44
Weighted Average Shares Outstanding
65.36M 62.65M 61.39M 45.47M 37.70M
Weighted Average Shares Outstanding (Diluted)
65.36M 62.65M 61.39M 45.47M 37.70M
Currency in USD

Bioventus Earnings and Revenue History